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Covalently modified halloysite clay nanotubes:
synthesis, properties, biological and
medical applications
M. Massaro,a G. Lazzara,*b S. Milioto,b R. Notoa and S. Riela*a
Halloysite (HNT) is a promising natural nanosized tubular clay mineral that has many important uses in
diﬀerent industrial fields. It is naturally occurring, biocompatible, and available in thousands of tons at low
cost. As a consequence of a hollow cavity, HNT is mainly used as nanocontainer for the controlled release
of several chemicals. Chemical modification of both surfaces (inner lumen and outer surface) is a strategy
to tune the nanotube’s properties. Specifically, chemical modification of HNT surfaces generates a
nanoarchitecture with targeted aﬃnity through outer surface functionalization and drug transport ability
from functionalization of the nanotube lumen. The primary focus of this review is the research of
modified halloysite nanotubes and their applications in biological and medical fields.
1 Introduction
Nanomaterials are defined as materials with at least one external
dimension in the size range from approximately 1–100 nanometres.
Until now, the behaviour of some nanomaterials like carbon
nanotubes, metal or metal oxide nanoparticles (e.g., gold, titanium
dioxide), quantum dots, and many others is well understood,
whereas others present greater challenges.
An emerging nanomaterial (Fig. 1), with appealing proper-
ties, is halloysite clay. The term ‘halloysite’, derived from
Omalius d’Halloy, who found the mineral in Angleur Lie´ge
Belgium, was employed for the first time in 1826 by
Berthier.1
The beginning of the extensive research on halloysite as a
mineral started in 1940 but only in the last 20 years it became
available in pure form and it was utilized both as a ‘‘cylindrical
mineral’’2 and as a ‘‘low-cost alternative nanotube’’.3
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HNTs are natural nanomaterials with a unique combination
of a hollow tubular nanostructure, large aspect ratio, mechanical
strength, broad potential in terms of functionality, biocompat-
ibility, and availability in large amounts at low cost. In addition,
halloysite is proven to be a bio- and ecocompatible material as
shown by several in vitro and in vivo studies.4–11
Finally, HNTs are among the few nanotubes with a diﬀerent
composition of inner and outer surfaces that allow for diﬀerent
modification methods by simultaneous immobilization of two
or more functional groups. Since 2008, the modifications of
halloysite surfaces opened up the use of these nanomaterials
for several applications in many fields. The main focus of this
review is the research of covalently modified halloysite
nanotubes and their biological and medicinal applications that
have been detailed in the literature.
2 Characteristics of halloysite
2.1 Structure
Halloysite (HNT) has a chemical formula for its cell unit
Al2Si2O5(OH)4nH2O that corresponds to kaolinite, a natural
aluminosilicate clay. It is a dioctahedral 1 : 1 clay mineral
present in soils. It is formed by weathering of several types of
igneous and non-igneous rocks, and thus it can be found
mainly in wet tropical and subtropical regions and weathered
rocks. Of course, each deposit is characterized by diﬀerent
purity grades, characteristic sizes and hydration states.
The layer unit consists of a corner-shared tetrahedral SiO4
sheet stacked with an edge-shared octahedral AlO6 sheet with
an internal aluminol group Al–OH. When n = 2 the mineral is
Fig. 1 Comparison of the annual number of scientific publications on the
‘‘halloysite nanotubes’’ term in the past 20 years. (Data analysis of pub-
lications was done using the SciFinder Scholar search system with the term
‘‘halloysite nanotubes’’, as on December 2016).
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called halloysite-10 Å due to its layer periodicity of 10 Å, whereas
heating halloysite-10 Å to 120 1C irreversibly dehydrates it to
halloysite-7 Å with n = 0.12
How halloysite nanotubes are formed is still under debate.13
There are few papers that report, from a theoretical point
of view, halloysite modelling to obtain information about the
tubular structure of this clay.
A first attempt to model halloysite nanotubes was made by
Guimaraes et al.,14 more recently, Ferrante et al. reported,15 for
the first time, the molecular ab initio calculations on spiral
halloysite nanotubes, both in the hydrated form and in the
anhydrous form. The authors found that, in the hydrated HNT
form, the water molecules should have a major eﬀect on
stabilizing the spiral structure compared to the unrolled one.
HNT hasmainly a hollow tubular structure in the sub-nanometre
range with an aspect ratio of ca. 20; the wall is constituted of
10–15 bilayers of aluminum and silicon oxide (Fig. 2). Depending
on the deposit the halloysite dimensions can vary. Generally
HNTs have a length in the range of 0.2–1.5 mm, while the inner
and outer diameters of the tubes are in the ranges of 10–30 nm
and 40–70 nm, respectively12,16,17 (Fig. 3).
2.2 Physicochemical properties
The techniques typically used to characterize HNT nano-
materials are: FTIR spectroscopy,19 used to analyze the outer and
inner active molecule loading, as well as UV-vis or fluorescence
spectroscopy; SEM and TEM to image the tubular structure;20
thermogravimetric analysis (TGA);21 z potential, pH, specific
surface area and pore volume used to determine the specific
interaction with suitable molecules.
The dielectric properties of aluminum and silicon oxides are
diﬀerent. Similarly, they undergo ionization in aqueous media
in an opposite way generating tubes with inner and outer
surfaces oppositely charged. This charge separation occurs in
water within a wide pH range from 3 to 8.22 Experimentally, the
charge separation is predicted by comparing the negative and
positive values for electrical z-potential of silica and alumina
surfaces in water, respectively (Fig. 4). Therefore, the outermost
layer of the halloysite tubes containing silica possesses an elec-
trical z-potential of ca. 30 mV in the pH range mentioned above.
This nanotube surface charge halloysite contributes to moderate
colloidal stability in water (2–3 h). The superimposition of the
negative silica outermost surface with the positive (alumina) inner
lumen results in the fact that the measured z-potential of HNTs is
less than that of pure silica particles (50 mV).
This charge separation is strictly dependent on the acid–
base properties of HNTs. To understand the aqueous behavior
of these peculiar nanotubes Pettignano et al.23 studied the
protonation/deprotonation equilibria of Si–OH and Al–OH
groups by a ISE-H+ potentiometric titration under variable
pH, ionic strength, ionic medium and concentration conditions
(Fig. 4). In particular, one protonation constant for the Si–OH
groups and two for the Al–OH groups were determined. The
protonation constant values increase with increasing ionic
strength in all ionic media, suggesting the presence of a back-
ground electrolyte which stabilizes the protonated species
through the formation of weak complexes between ions of the
supporting electrolytes and the protonated species (Fig. 5).
Fig. 2 (a) Schematic representation of the rolled structure of halloysite;
(b) TEM and AFM images of HNT edges.
Fig. 3 FE-SEM image of halloysite on Si-wafer (left) and schematic
illustration of the crystalline structure of halloysite (right). Reproduced
from ref. 18 with permission from The American Chemical Society.
Fig. 4 Charge separation between the inner and outer surfaces of HNT.
Reproduced from ref. 23 with permission from The American Chemical Society.
Fig. 5 Distribution diagrams of the HNT1 (dashed lines) and HNT2
(continuous lines) protonated and weak complex species vs. pH in NaCl,
at I = 0.100 mol dm3. Experimental conditions: CHNT1 = 1 mmol dm
3,
CHNT2 = 4 mmol dm
3, T = 298.15 K. Reproduced from ref. 23 with
permission from The American Chemical Society.
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2.3 Halloysite biocompatibility
The increasing interest in HNT nanomaterials could result, in
the long term, in the release and accumulation of the nanoclay
in the environment with consequential damage to human
health and/or vegetation.
The first example of the phytotoxic study on halloysite
was reported by Riela and Scialabba et al.,9 who performed
experiments on Raphanus sativus L to develop a quantitative
risk assessment model for predicting the potential impact of
HNT on plant life.
Halloysite is proven to be a biocompatible material in several
recent reports on cell cultures24 and invertebrate models.7 The
uptake and toxic eﬀects of halloysite have been investigated
using human cell lines, namely breast cancer cells,24 thyroid
cancer cells,25–27 hepatic cancer cells28,29 and epithelial adeno-
carcinoma cells.24 The toxicity of HNT was tested after 48 hours of
incubation with fibroblast and human breast cells.24 It emerged
that it is non-toxic and it is much less harmful than ordinary
sodium chloride salt. The introduction of a functionality on the
HNT surface could, in principle, induce some adverse effects.
For example, chitosan scaffolds for tissue engineering doped
with halloysite were found to induce no significant adverse
effects on the attachment and development of fibroblasts.
Composite halloysite-doped dental scaffolds stimulated the
growth of fibroblast cells.30 In contrast, the functionalization
of HNT with organic groups that themselves possess biological
activities, such as triazolium salts, confers an antiproliferative
activity to halloysite.25,29
The interaction of halloysite nanotubes with microscopic algae
Chlorella pyrenoidosa was also investigated. Lvov et al.31 demon-
strated that there was no penetration of the nanomaterials into
the cell interior. It was also reported that halloysite nanotubes
were safe for one of the most common fresh water ciliate protists
Paramecium caudatum.4 Similarly, HNTs exhibit no toxicity
towards Escherichia coli bacteria32 and yeast cells.33
Fahkrullin et al.7 reported the first example of the evaluation
of halloysite toxicity in vivo on free living nematodes (worms)
Caenorhabditis elegance. The authors demonstrated that HNTs were
found exclusively in the intestines of the worms and no nanotubes
were detected outside the intestines of the nematodes (Fig. 6).
Therefore, halloysite within a wide range of concentrations does
not damage the organism of the nematodes, inflicting only
mechanical stress on the alimentary system. Halloysite is eﬃciently
removed from an organism by macrophages and therefore it is
considered a healthy and biocompatible material, though it may
penetrate into the cell interior as shown by confocal microscopy
experiments.24 It turned out that accumulation of HNTs within
cells does not prevent their proliferation and they are taken up into
the cells surrounding the nuclei. The introduction of targeting
moieties on halloysite involves an accumulation of halloysite into
the cell, with specific interaction with cell nuclei, as confirmed by
fluorescence microscopy. The specific functionalization of HNT
with sugar moieties (HNT–CD) generates a high propensity to cross
cell membranes, penetrating into the cell nucleus (Fig. 7).27
However, because there are not biological mechanisms of alumino-
silicate degradation in the body, halloysite is not biodegradable,
and therefore it cannot be injected intravenously. The use of
modified halloysite is limited as an active ingredient in external
medical treatment with slow release of encapsulated drugs (e.g., in
creams, implants, or wound treatment of tissues). Several studies
were performed in order to assess the cytotoxicity of HNT for the
potential of oral dosage. In particular Shaib et al.34 studied, by
means of WST-1 assay, the effect of the nanomaterial on two cell
lines, namely the colorectal carcinoma cells HCT116 and the
hepatocarcinoma cells HepG2. In addition, the authors studied
the cytogenetic toxicity of HNT by determining its activity against
human peripheral lymphocytes by means of the mitotic index
assay. The obtained results highlighted that halloysite nanotubes
are safematerials and they can be used in various oral drug delivery
systems, particularly as diluents/filler materials in tablets, capsules,
and suspensions, without causing toxicity to the absorptive sites
and the first accumulating organ. In this context, HNTs were used
as tablet excipients with excellent compression properties for the
delivery and controlled-release of nifedipine. This formulation
ensured a sustained release up to 20 hours of the active agent
and protected it from photo-degradation.35
Finally, Mitrokhin et al. recently demonstrated that halloy-
site can be classified as a hazard class 4 material (low hazard
substance).36
Fig. 6 Dark-field microscopy imaging of distribution of halloysite in
C. elegance worms: (a) inside the foregut; (b and c) in the midgut (no
nanotubes in embryos, uterus, and vulva were detected); (d) inside the hindgut.
(below) In vivo eﬀects on C. elegance growth and fertility. Reproduced
from ref. 37 with permission from The Royal Society of Chemistry.
Fig. 7 Fluorescencemicroscopy images of the HNT–CD uptake by 8505C.
The 8505C cell membrane (red) with co-localized HNT–CD (green) inside
nuclei at 24 h.27
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3 Modification of halloysite
Among the diﬀerent phyllosilicate nanomaterials (silicate
based layer structure) such as kaolin and montmorillonite,
halloysite has distinct advantages. First of all it is composed
of small tubes that, compared to other tubular nanomaterials,
have dimensions that allow for macrophage removal of nano-
particles from a living organism.12 In addition the empty HNT
lumen can be loaded with active molecules (drugs) or alterna-
tively, drugs can be absorbed onto the external HNT surface.
Furthermore, the possibility of both loading the drug into
the inner lumen and grafting it onto the outer surface oﬀers
distinctive additional advantages, i.e. synergism between drugs
with diﬀerent biological properties.
The remaining sections are focused on the introduction of
chemical modifications on the HNT external surface and the
simultaneous supramolecular interactions of drugs with the
HNT lumen.
The most attractive feature of halloysite is its inner lumen
with a diameter capable of entrapping chemical agents such as
macromolecules, drugs, DNA, proteins, nanodots38 and other
chemically active agents, e.g., anticorrosion for protective
coating. In this context, the empty lumen of halloysite acts
as a miniature container for processes, which benefit from
sustained molecular release.
The use of halloysite as a nano-container for drug loading
and release was firstly introduced by Price, Gaber and Lvov,
who used the nanotube as a carrier for oxytetracycline HCl
(a water soluble antibiotic); khellin (a lipophilic vasodilator)
and nicotinamide adenine dinucleotide (NAD) (an important
co-enzyme).2 Successively, Veerabadran et al.22 reported that
halloysite can load and release dexamethasone and furosemide
in a controlled manner.
Electrostatic interactions were used to selectively load, into
the positively/negatively charged HNT lumen/outer surface,
protein with diameters of 3–8 nm; in particular, the immobi-
lization of laccase, glucose oxidase, lipase, and pepsin was
reported.39
To avoid the fast release of the active agent from the HNT
lumen, Fakhrullin et al.40 fabricated a novel drug delivery
system based on HNTs loaded with brilliant green as a drug
model, and coated with dextrin to clog the tube opening until
the cell absorbs these nanocarriers whereupon the sugar can be
cleavable by intercellular glycosyl hydrolases (Fig. 8). They
found that the accumulation and enzymatically induced release
of drugs occurred exclusively in cells prone to internalization of
the nanotubes with higher proliferation rates, which is a
characteristic of tumoral cells. Therefore, the developed nano-
material does not damage healthy cells and as a result, drug-
loaded dextrin-HNTs will be accumulated selectively in tumor
cells (Fig. 9).
However, pristine halloysite shows only weak interactions
with guest molecules through hydrogen bonding or van der
Waals forces,41 and fast and non-controlled release.42 There-
fore, it is clear that the functionalization of halloysite surfaces
is crucial to solve the aforementioned drawbacks. Fortunately,
the diﬀerent inside/outside halloysite chemistry allows for
selective functionalization of the surfaces, which increases
the potential applications of HNT.43 The covalent modification
of the outer surface is most commonly achieved by grafting
silanes via condensation between hydrolyzed silanes and the
surface hydroxyl groups of the HNTs located on the edges or on
external surface defects.37
The grafting reactions can occur in toluene, in water/alcohol
mixtures or under solvent-free conditions under microwave
irradiation. Over the years, numerous silanes have been grafted
onto HNTs with the aim of preparing nanomaterials with
hierarchical nanostructures (Table 1).
For example, the modification of the halloysite nanotubes
by g-methacryloxypropyl trimethoxysilane increases the inter-
actions with the ethylene propylene diene monomer and the
degree of dispersion of the HNTs in the polymeric matrix.44
Once a specific organosilane is grafted onto the HNT exter-
nal surface, it is possible to introduce other functionalities by
modifying the organosilane terminal group. For example, it is
possible to obtain a HNT-COOH nanomaterial by reacting the
amino functionality of a APTES functionalized HNT with maleic
or succinic anhydride in DMF (Fig. 10).45–47
In another work, amine-terminated dendritic groups were
attached on the surface of HNTs by a divergent synthesis starting
from HNT-APTES and methyl methacrylate (MA) as monomers,
followed by reaction with ethylene diamine to obtain a third
generation dendrimer functionalized halloysite (Fig. 10).48
Fig. 8 Fabrication of brilliant green-loaded HNTs and the subsequent
coating with dextrin stoppers. Reproduced from ref. 40 with permission
from the Nature Publishing Group.
Fig. 9 (a) TEM image of brilliant-green-loaded halloysite; (b) SEM image
of a dextrin cap at the end of the functionalized nanotube; (c) TEM images
of A549 cells incubated with dextran-coated clay nanotubes; (d) resazurin
assay results demonstrating the LD50 value of BG-loaded halloysite
for A549 cells. The insets show the AFM images of the distribution of
DX-halloysite in the A549 cells. Reproduced from ref. 40 with permission
from the Nature Publishing Group.
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The HNT-NH2 scaﬀolds were also used as precursors for poly-
mer attachment on the HNT external surface. Several polymers
have been covalently grafted by means of simple condensation
reactions, such as polyethyleneimine49 or poly N-isopropyl
acryl amide.50
4 Application of modified HNTs as
drug carrier and delivery systems
The applications of HNT nanomaterials are expected to increase
as a consequence of the modification of halloysite surfaces,
Table 1 The chemical composition of silanes used for the modification of HNTs
Fig. 10 Examples of further functionalization of APTES modified HNT.
Review Journal of Materials Chemistry B
This journal is©The Royal Society of Chemistry 2017 J. Mater. Chem. B, 2017, 5, 2867--2882 | 2873
which opens up alternative ways to the use of nanoclay, in
particular in the field of drug delivery.
The advantage of using a halloysite as a nanocontainer for active
molecules lies in the benefit of their sustained release over time.
Compared to the compound dissolved in water, the molecules
interacting with HNT exhibit much longer release rates, indicating
nanopore controlled diﬀusion from HNT. Usually, release rates
increase from few minutes to 20 h in the presence of HNT. For
example, nicotinamide adenine dinucleotide (NAD) was released in
5 h while dexamethasone release takes place in 10–15 h, where only
60% of the drug was released in the first 6 h. In addition, the
possibility of introducing HNT as a filler in polymeric or hydrogel
matrices further slows the release rate of a given compound.
Veerabadran et al.70 elaborated a layer by layer assembly (LbL)
by sequentially absorbing layers of polyelectrolytes of diﬀerent
molecular weights, with a final layer of silica nanoparticles. LbL
shell assembly was applied to dexamethasone loaded halloysite to
slow the drug release from the nanotubes. The loading of the drug
was confirmed by porosity measurements that showed a reduction
in the pore volume of the dexamethasone loaded HNT compared to
the unloaded tube. The drug loading was estimated, by UV experi-
ments, to be ca. 7 vol%, which is approximately the lumen volume.
The covalent functionalization of the external surface of halloysite
with 3-aminopropyltriethoxysilane (APTES) improved ibuprofen (IBU)
loading by creating an electrostatic attraction between the introduced
aminopropyl groups of the grafted APTES and the carboxyl groups
of IBU. The electrostatic attraction was stronger than the hydrogen
bonding in the case of IBU loading in unmodified halloysite.71 The
release of IBU from the APTES-modified and pristine HNT fits
with the modified Korsmeyer–Peppas model.† The strong affinity
(electrostatic attraction) in APTES-modifiedHNT slowed the release of
IBU and changed the release mechanism from Fickian diffusion in
the pristine HNT to non-Fickian diffusion in the APTES-HNT.42
The performance of HNT functionalized by APTES was also
studied for the loading and release of aspirin.57 The results
obtained show that the introduction of APTES on the HNT surface
improved the drug loading from 3.84 to 11.98 wt% with respect to
pristine halloysite. In addition, the obtained hybrid significantly
enhances the dissolution rate of the drug by creating a burst
release with the first hour followed by sustained release for
ca. 16 hours compared with the free aspirin. Furthermore, if
compared with drug release from pristine halloysite, the aspirin
dissolution rate from the modified HNT is slower.
A similar system was used by Kumar-Krishnan et al. to obtain
a novel nanomaterial able to immobilize eﬃciently, after AgNP
coating, enzyme glucose oxidase (GOx) (Fig. 11).72 The immobi-
lization of GOx is crucial since the direct physical adsorption of
enzymes over the solid matrix often leads to partial deactivation
of their biocatalytic functions and consequently direct electron
transfer is not observed.73 Similarly, the immobilization of
enzymes over 3D redox polymer matrices significantly impacts
the charge-transfer eﬃciency. The modification of HNT improves
the GOx immobilization but also revealed a high electrocatalytic
activity for glucose reduction and facilitating enhanced charge
transport. The glucose detection sensitivity of the composite
electrodes was as high as 5.1 mA mM1 cm2, which is consider-
ably higher than the glucose sensitivity of the electrode fabricated
by a non-functionalized HNT/AgNP surface. The modification of
the halloysite surface with succinic anhydride, as mentioned in
the Introduction, is a useful tool to convert the surface hydroxyl
groups to carboxyl groups creating a suitable scaﬀold available
for further functionalization. The so-obtained HNTs-COOH was
connected to biocompatible chitosan via N-(3-dimethylamino-
propyl)-N0-ethylcarbodiimide/N-hydroxysuccinimide reaction, form-
ing the HNTs-g-chitosan hybrid.45 Afterwards, curcumin was loaded
onto the surface of HNTs-g-chitosan through supramolecular
interactions. The covalent grafting of chitosan on HNTs
Fig. 11 Schematic illustration of the selective modification of the HNTs and subsequent grafting of AgNPs and site-specific covalent immobilization of
the GOx enzymes.
† Ft = kt
n, where Ft is the drug release fraction at time t, k is the kinetic release
constant, t is the release time and n is the characteristic diﬀusion exponent,
depending on the release mechanism and the geometry of device. If Fickian diﬀusion
occurred, n decreased to 0.5 for slab/cylinder/sphere. If non-Fickian (anomalous)
diﬀusion dominated, the n value was between the above value corresponding to the
polymer chain relaxation (n o 1) for a slab/cylinder/sphere. Thus, through determi-
nation of the n value, the drug release mechanism could be identified.
Journal of Materials Chemistry B Review
2874 | J. Mater. Chem. B, 2017, 5, 2867--2882 This journal is©The Royal Society of Chemistry 2017
increases the hemocompatibility, stability in body liquid, the
loading eﬃciency of curcumin, and the cytocompatibility
(Fig. 12). HNTs-g-chitosan acts as a highly potent killer of
various cancer cells in vitro especially with higher cytotoxicity
to EJ human bladder cancer cells compared to free curcumin
from the cell viability assay. In addition, the supramolecular
hybrid HNTs-g-chitosan/curcumin was successfully taken up by
cancer cells, as confirmed by fluorescence microscopy.
In recent work,74 the same authors reported the application
of the HNT-g-chitosan system as carrier for doxorubicin (Doxo).
They found that the system is highly eﬃcient in the drug
loading preserving Doxo properties. Furthermore, release tests
show a controllable and sustained release in the ‘‘tumoral
environment’’ instead of under normal physiological conditions.
Doxo release from the HNT-g-chitosan system was, indeed, very
slow in PBS solution (only 6.40% was released after 45 h), while
it was fast in the cell lysate, where 61.9% of release was
observed after 12 h.
4.1 Prodrugs based on HNT
The first attempt to obtain a HNT based prodrug reports the
curcumin covalently linked on the halloysite external surface
through GSH- or pH-responsive bonds (HNT-Cur prodrug)
(Scheme 1).28
The morphology and the size of the HNT prodrug were
characterized by SEM and dynamic light scattering (DLS).
Measurements of the particle size using DLS revealed an apparent
hydrodynamic radius of 570 nm for the HNT-Cur prodrug.
This value is ca. 2 times larger than that expected for a single
diﬀusive HNT particle (240 nm).75 The outer surface modifica-
tion with Cur is expected to enhance the hydrophobic lateral
interaction between nanotubes. The formation of supramole-
cular aggregates is therefore evidenced by slow diﬀusion or
hydrodynamic radius increase.
On the other hand, SEM images of the dried samples show
that the tubular morphology is preserved in the HNT-Cur prodrug
as well as the characteristic sizes of the imaged nanotubes that
are 80 nm and 720 nm for the average external radius and
length, respectively.
The halloysite prodrug showed relatively good stability
under normal physiological conditions, and as a consequence
of the dual stimuli-responsive nature of this nanomaterial,
enhanced release of curcumin was observed upon exposure of
the prodrug to GSH-rich or acidic conditions similar to the
cellular microenvironment of hepatic cancer cells.
The release of curcumin from the HNT-prodrug was fitted
with the Korsmeyer–Peppas model.† The results showed that
the value of kinetic constant in an acidic environment was
lower than 96% with respect to that at pH 7.4. This result
indicates that different release mechanisms occur as a function
of pH, in particular, a fast diffusion mechanism of curcumin
(k = 14  1 min1, n = 0.08) through the dialysis membrane at
pH 7.4 as a consequence of the instantaneous disulphide bond
reduction by GSH. In contrast, the HNT-Cur prodrug exhibits
a sustained-release feature (k = 0.6  0.2 min1, n = 0.6) at pH 1
in agreement with the hydrolysis of the imine bond.
The antiproliferative in vitro studies on two cell lines of
hepatocellular carcinoma showed that the HNT-Cur prodrug
induced high cytotoxicity with respect to the free curcumin or
pristine HNT. The opportunity to increase the release of curcumin
from the nanoparticle by intracellular GSH appears very interesting,
especially for hepatocarcinoma, because GSH is typically concen-
trated in hepatic cells. Furthermore, it was demonstrated that
the HNT-Cur prodrug retains its antioxidant characteristics
that could be crucial in anticancer therapy.
Another prodrug system based on halloysite was obtained by
the functionalization of the HNT external surface with triazole
molecules.
Triazoles and their derivatives, indeed, occupy a central
position among the most significant compounds that constitute
pharmaceutically and medicinally important drug centers.76
Several triazoles have been reported to possess antifungal,
antibacterial and antitumoral activities.25 For the above reasons
halloysite was firstly modified with 3-azidopropyl-trimethoxy-
silane and the nanomaterial obtained was used as a scaﬀold
for the covalent grafting of triazolium ionic liquids (Scheme 2)
to obtain a HNT-triazolium prodrug. The cytotoxicity of the
new nanomaterial obtained was tested, by the MTT or MTS
assay, against diﬀerent tumoral cell lines, namely 8505C,
BCPAP, C643, SW1736, HA22T/VGH, Hep3B and HepG2.
It was found that the introduction of triazole moieties on
halloysite involves an increase in the cytotoxicity of the HNT-
triazolium prodrug with respect to pristine HNT with an IC50 of
40.0  14.6 mM.25
Fig. 12 Curcumin loaded on the HNTs-g-chitosan hybrid. Reproduced
from ref. 45 with permission from The Royal Society of Chemistry.
Scheme 1 Schematic representation of the synthesis of the HNT-Cur
prodrug.
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4.2 Stimuli-responsive carriers
As far as the drug delivery issue is concerned, the development
of a system that responds to a specific stimulus for the
triggered release of the active component is often requested.
The main advantage of this kind of stimuli-responsive prodrug
is the reduction of side eﬀects and the increase of antitumor
activity owing to tumor-specific drug release.
Stimuli responsive polymers are a class of compounds that
show conformational changes upon an external stimulus such
as temperature, light, pH, and so on. Therefore, covering the
halloysite surface with these types of polymers could generate
novel materials with lots of potential applications in the
fields of scaﬀolds for tissue engineering, biosensors and drug
delivery systems.
4.2.1 pH-Sensitive delivery. Among the diversity of poly-
mers that can be used for this purpose, pH-sensitive polymers
have been attracted a lot of interest for their application in
medicine. Poly(N,N-dimethylaminoethylmethacrylate) (PDMAEMA)
is a pH-responsive polymer that possesses specific biological
properties such as antibacterial properties and biocompatibility.
For the above mentioned reasons HNTs were functionalized
with PDMAEMA and used as drug delivery systems for diphen-
hydramine hydrochloride and diclofenac sodium salt (Scheme 3).77
HNT was functionalized with APTES by the classic silane coupling
reaction. Then, a-bromoisobutyryl bromide (BiBB) was anchored to
the amine groups by an acylation reaction to yield HNT-Br and,
finally, initiator-anchored HNT was used as a precursor to attach
PDMAEMA onto the HNT external surface (Scheme 3). The so
obtained nanomaterial was employed for DPH and DS loading,
and the in vitro release of drugs was studied under diﬀerent pH
conditions. The DPH or DS release rate from the HNT–PDMAEMA
was much slower than the release rate from pristine HNT (fast).
This result is due to the polymer chains on the HNT surface
that exert a slowing effect on the release of drugs. Indeed, the
movement of drug molecules from the inner space toward the
lumen is hindered by the polymer chains and results in a low
release rate. It was also found that the release of drug molecules
from the nanomaterial is highly dependent on pH (Fig. 13).
Indeed, in acidic medium, amine groups of PDMAEMA chains
are protonated and formed a positively charged polyelectrolyte.
The repulsion between the protonated PDMAEMA chains
grafted on HNT resulted in a stretched chain conformation.
This also affected the release behavior of HNT–PDMAEMA
upon increasing the release rate of trapped DPH molecules
among the polymer chains. Moreover, repulsions between the
DPH molecules and protonated PDMAEMA chains accelerate
the release of drug molecules.
4.2.2 Thermo-responsive carriers. Another stimuli-responsive
carrier, in particular a thermo-responsive system, was obtained
by introducing on the halloysite surface a thermo-responsive
Scheme 2 Schematic representation of the synthesis of the triazolium salt modified HNT.
Scheme 3 Schematic representation of the synthesis of the functionalization of HN–NH2 with BiBB and subsequent grafting of PDMAEMA chains.
Fig. 13 Cumulative release of DPH from HNT and HNT–PDMAEMA-1
at two different pH values. Reproduced from ref. 77 with permission
from Elsevier.
Journal of Materials Chemistry B Review
2876 | J. Mater. Chem. B, 2017, 5, 2867--2882 This journal is©The Royal Society of Chemistry 2017
polymer such as poly-N-isopropyl acrylamide (PNIPAAM).50
This polymer was attached, by amide condensation, on the
external HNT surface previously modified with 3-aminopropyl-
trimethoxysilane (Fig. 14). The synthetic route adopted in this
work rendered a large surface density of polymers onto the
nanotubes. Temperature-responsive features were observed as
the PNIPAAM corona undergoes a coil-to-globule transition at
the lower critical solution temperature (LCST), around 32 1C.
This material was used for curcumin delivery; the drug
was loaded onto the carrier at 25 1C, whereas the drug release
was investigated at 37 1C in a medium that simulates the
gastro-intestinal transit (Fig. 15). The in vitro release tests
showed a targeted and sustained release of the active species
into the intestine.
5 Dual drug co-delivery
A novel dual drug co-delivery system was proposed by Lazzara
and Riela et al. by the loading of curcumin or cardanol on the
HNT-triazolium prodrug.25,29
The successful loading was confirmed by several techniques.
In particular, with regard to curcumin loading, TGA data
showed the co-existence of two kinds of curcumin species,
one encapsulated in the inner lumen, and the other adsorbed
on the external surface (Fig. 16).75,78
With regard to cardanol, HPLC analysis highlighted the
strong interaction occurring in HNT-triazolium prodrug/Card
supramolecular complexes.
In comparison with pristine HNT, these systems have
the advantage of high drug encapsulation eﬃciency as well as
pH-controlled and sustained release capabilities. Moreover, the
triazole moiety on the HNT external surface was found to have a
synergic eﬀect with curcumin or cardanol, which makes the
functionalized HNT an ideal carrier for anti-cancer therapies
as confirmed by MTT and MTS assays on several tumoral
cell lines.
The covalent linkage of a given drug on a suitable matrix is
an important task in the development of new drug delivery
systems since, besides the possibility of introducing a stimuli-
responsive behavior, it is expected to minimize the undesired
leaching of the drugs during circulation in the human body.
Based on the above considerations, the halloysite surface was
covalently functionalized with an antioxidant molecule, such as
Trolox, that could benefit from a covalent linkage owing to a
reduction in their toxicity by decreasing their steady-state
concentration in the system. The first example of a synergic
nanoantioxidant was based on Trolox covalently linked on the
external surface of halloysite and quercetin loaded into the
HNT lumen (Fig. 17a).79 This novel nanomaterial represents
the prototype for a general design strategy expected to aﬀord
improved antioxidant halloysite nanotubes, in which one main
phenolic antioxidant function (like Trolox) is exposed on the
outer surface and is readily available to trap free radicals,
whereas a second co-antioxidant (like quercetin) is loaded in
the inner lumen and is slowly released to regenerate the main
antioxidant and aﬀord a prolonged synergistic protection
(Fig. 17b).
Co-delivery of two or more biological active compounds
has attracted increasing attention because it is known that
compared to conventional single-agent treatment, multi-agent
therapy can promote the synergism of diﬀerent drugs, increase
therapeutic target selectivity, and overcome drug resistance
through distinct mechanisms of action.
Fig. 14 Schematic representation of temperature triggered loading and release of curcumin into HNT modified with poly(N-isopropylacrylamide).
Fig. 15 Cumulative release of curcumin from HNT-PNIPAAM at pH 1.0
and pH 6.8.
Fig. 16 TGA data revealed the co-existence of two diﬀerent curcumin
species loaded on HNT.
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Recently Zhou et al. reported a dual-drug delivery system
comprising poly(L-lactide) (PLLA)/HNT electrospun mats capable
of co-delivering hydrophilic (polymyxin B) and hydrophobic
(dexamethasone) drugs.80 Filling of electrospun PLLA mats
with HNTs shows that the nanocomposite obtained presents
an increase in the breaking stress and, in addition, the mats
degraded more rapidly when compared to pure electrospun
mats, under the same conditions. Moreover, the presence of
HNTs in the fibers facilitated the tunable release of polymyxin
B and dexamethasone. The composite fiber mats exhibited
considerable antibacterial activity and put forward the use of
halloysite as wound-dressing materials.
Another dual-drug HNT delivery system was obtained by the
covalent linkage of b-cyclodextrin (b-CD) units on the HNT
external surface.64 The covalent binding of cyclodextrin instead
of a supramolecular approach to the HNT surface allows the
fabrication of an organic–inorganic hybrid material with great
stability, control over the degree of functionalization, and the
data reproducibility. Moreover, the presence of two cavities offers
the remarkable possibility for a simultaneous encapsulation of
two or more drug molecules with different physicochemical
properties, followed by a different path release in agreement
with the cavity that encapsulates each drug. In this context,
different systems were developed (Scheme 4).
One of them was obtained by grafting amphiphilic cyclo-
dextrin units onto the nanotube surface and the new multi-
cavity nanomaterial was used for the simultaneous co-delivery
of silibinin and quercetin.26 HPLC measurements and fluores-
cence spectroscopy highlighted that silibinin interacts prefer-
entially with the HNT lumen, while quercetin does with the
cyclodextrin cavity. Thermogravimetric analysis showed that
the new materials can load the drugs and, therefore, they are
suitable nanocontainers for the co-delivery of two drugs that
could have synergic eﬀects in anticancer therapy as demon-
strated by in vitro cytotoxicity assays. In addition, the inter-
action between cells and the carrier, analyzed by fluorescence
microscopy, revealed that the materials were taken up into cells
surrounding the nuclei (Fig. 18).
Since drug delivery to specific targets has become an impor-
tant issue for promoting the selectivity of drugs to diseased
Fig. 17 (a) Schematic representation of quercetin loading into HNT-Trolox. (b) Synergic eﬀect in HNT-Trolox/Que: the experimental stoichiometric
coeﬃcient in MeCN (blue bars,SD, N = 3) compared to the theoretical one, as calculated from the sum of contributions of HNT-Trolox (green bars) and
HNT/Que (red bars) alone.
Scheme 4 Schematic representation of the synthesis of the HNT multicavity and HNT–CD.
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sites and reducing toxicity against normal cells, the introduc-
tion of targeting functionalities as well as the glycocluster eﬀect
on halloysite systems was achieved by attaching on several b-CD
core mannose units (Scheme 4).27 Also in this case, the novel
nanomaterial was employed for the co-delivery of curcumin and
silibinin. Release studies showed that pH deeply aﬀects the
kinetic course of the process, and at diﬀerent pH values,
indeed, a complementary behavior of drugs was observed. In
particular, curcumin showed a slow release in the simulated
gastric fluid, whereas a more rapid release rate was observed
in the simulated intestinal fluid. In contrast, silibinin was
better released in an acidic environment (Fig. 19). This com-
plementary behavior, mainly due to the diﬀerent ‘‘interaction
sites’’ on the HNT–CD system could be advantageous for the
actual application to maintain effective concentration in the
body and reduce the maximum extent of the side effects to
the stomach.
In order to better understand the release behavior of silibi-
nin and curcumin under diﬀerent pH conditions, the in vitro
release data were fitted to two models to analyze the kinetics
and the release mechanism of both molecules. The experi-
mental data were analyzed using (DEM) and Korsmeyer–Peppas
models. The results showed that the release of silibinin at
pH 1.0 and curcumin at both pH values follows the Korsmeyer–
Peppas model with an n value lower than 0.5 in all cases,
indicating that the release of biological molecules was con-
trolled by a drug diffusion process. It was found that the release
mode of silibinin in neutral solution follows the double exponen-
tial model. Therefore, the release of silibinin and the simultaneous
release of curcumin were observed. The dual-drug loaded system
showed an improved cytotoxic activity against 8505C cell lines
compared to free drugs. The associated activity might be attributed
to the enhanced cellular internalization due to carbohydrate-
receptor-mediated endocytosis with nuclear specific targeting
as highlighted by fluorescence microscopy. This result demon-
strates that halloysite could penetrate the cellular membrane
and surrounding cell nuclei.27
6 Functionalized halloysite nanotubes
and biopolymers for biological
applications
Biopolymers are usually used for controlled drug delivery.
However, pristine biopolymer matrices suﬀer from some dis-
advantages such as the burst release of drugs and weak stability.
Besides the improved mechanical properties,19 inorganic
materials have been used to improve the swelling behavior,
drug loading eﬃciency and controlled release behavior of the
pristine biopolymer matrices via electrostatic interactions and
hydrogen bonding. Therefore, the combination of HNTs and
biopolymers should be a feasible approach to prepare carriers
for sustained drug release.81
Fig. 18 Fluorescence microscopy images of the HNT multicavity uptake by 8505C. An 8505C cell membrane (red) with a co-localized HNT multicavity
(green) surrounding cell nuclei at 24 h.
Fig. 19 Kinetic release of (a) silibinin; (b) curcumin in 0.1 M HCl solution and pH 7.4 phosphate buﬀer from HNT–CD hybrids.
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Fan et al.82 reported the preparation of HNT-sodium alginate/
hydroxyapatite nanocomposite beads by the generation of
hydroxyapatite (HA) in a nanosized regime. To this aim the
sol–gel transition of the HNT-sodium alginate dispersion was
used to produce the nanoparticles in situ. The beads were used
for the loading and release of diclofenac sodium. The combi-
nation of HNTs with a tubular structure and HA nanoparticles
could limit the flexibility of the alginate polymer chains, which
is the principal reason for the enhanced loading of the active
pharmaceutical component. Moreover, a sustained release
behavior is achieved.
Magnetic microspheres, 2-hydroxypropyltrimethyl ammonium
chloride chitosan/Fe3O4/halloysite nanotubes/ofloxacin (HACC/
Fe3O4/HNTs/OFL), for the controlled release of OFL were
synthesized by in situ crosslinking with glutaraldehyde in the
spray-drying process (Fig. 20). The magnetic microspheres were
employed as carriers for ofloxacin. It was found that HNTs have
a remarkable eﬀect on the roughness of the surface, which
decreases the entrapment eﬃciency and accelerates the release
of OFL though an increase in HNT content, and are conducive
to the adsorption of OFL into HNTs.
However, the introduction of HNTs can improve the bio-
availability of OFL in the gastro-retentive drug delivery system.83
Due to its features, among them hemostatic and anti-
infectional activities, chitosan can also be used for wound
healing. Chitosan can accelerate the infiltration of polymorpho-
nuclear cells at the early stage of wound healing, followed by
the fabrication of collagen by fibroblasts.
The addition of HNTs aids in faster re-epithelialization and
collagen deposition. These properties are attributed to the
particular characteristics of HNTs and their combination with
chitosan. The results show that these advanced HNT–chitosan
bionanocomposite sponges have many potential applications
for diabetic, burn and chronic wound infections.84
Thanks to the high performance and biocompatibility,
HNT–chitosan and HNT–alginate bionanocomposites also have
possible applications in bone tissue engineering. In order to verify
cell attachment and viability on the bionanocomposites, several
studies were carried out. Cell morphology results exhibited that
cells can be attached and grown well on the chitosan–HNTs.6,85
The introduction of HNTs caused changes in the surface nano-
topography of chitosan and involved an increasing roughness of
the bionanocomposite. A rougher surface and the existence of
the Si element in the HNTs–chitosan bionanocomposite surface
are beneficial to the attachment of the cells.
Bionanocomposite films based on chitosan reinforced with
HNT were able to trap horseradish peroxidase (HRP). Besides
its use as a immobilization matrix, chitosan/HNT was proposed
as a binder to improve the adhesive features to an electrode
surface. In particular, the obtained HNT–chitosan film could
promote the direct electrochemistry of HRP and catalyze the
reduction of H2O2.
86 Therefore, this hydrophilic HNTs–chitosan
bionanocomposite could give a new appealing platform for
additional studies on the redox behavior of proteins. The use
of a direct electrochemistry approach is crucial for the develop-
ment of innovative biosensors.
Gorrasi et al.87 reported the synthesis and characterization
of bionanocomposites based on pectins and nano-hybrids of
Fig. 20 Preparation of the hydroxypropyltrimethyl ammonium chloride
chitosan/Fe3O4/halloysite nanotubes/ofloxacin (HACC/Fe3O4/HNTs/OFL)
microsphere. Reproduced from ref. 83 with permission from Elsevier.
Fig. 21 (a) Pectin/HNT/CB[6]/peppermint oil bionanocomposite film. (b) Release profile of menthone (expressed as mg of menthone per cm2 of film)
from the pectin based films in 50% v/v ethanol. Black circles refer to pristine pectin at 25 1C, while green and red circles refer to the pectin/HNT/CB[6]
bionanocomposite at 4 and 25 1C, respectively. (c) Antibacterial activity of pectin/HNT/PO films against E. coli and S. aureus at 4, 37 and 65 1C incubated
for 30 min.88
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HNTs loaded with rosemary essential oil, as antimicrobial
agents, for their potential application in food packaging. The
halloysite presents improved mechanical and barrier proper-
ties, allowing a much slower release of rosmarinic acid com-
pared to the molecules directly dispersed in the pectins and a
preliminary evaluation of antimicrobial activity indicated the
potential application of the obtained composites in active food
packaging, opening new aspects for pectins-antimicrobials as
coating agents for their application in the food packaging field.
The loading of essential peppermint oil in a novel edible
biodegradable film based on pectin reinforced with functionalized
HNT was also reported (Fig. 21).88 In particular, supramolecular
interactions between HNT surfaces and cucurbit[6]uril (CB[6])
molecules89 facilitated the synthesis of a hybrid nanofiller with
high solubilization capacity towards essential oils.
The ‘‘multi-pocket’’ HNT/CB[6] filler showed a significant
enhancement (ca. 10 times) of the HNT adsorption ability
towards peppermint oil, which was induced by the addition of
CB[6], as confirmed by HPLC analysis. On this basis, HNT/CB[6]
loaded with the essential oil was filled in a pectin matrix using
the aqueous casting method under vacuum as well as a pepper-
mint oil saturated atmosphere. With the ultimate goal of using
this bionanocomposite for food packaging applications, some
release tests were performed in the simulant food solvent. These
results showed that the bionanocomposite could be considered
as a thermo-sensitive packaging system. With respect to anti-
microbial properties, in vitro experiments for Escherichia coli
(Gram-negative) and Staphylococcus aureus (Gram-positive) iso-
lated from food sources revealed that the composite biofilm is
more eﬃcient at higher temperatures (Fig. 21c).
7 Conclusions and perspectives
Halloysite nanotubes aremade of natural aluminosilicate clay with a
hollow tubular structure in the sub-micrometer range and dimen-
sions suitable for macrophage removal from living cells. They are
classified as class 4materials (low hazard substances). HNTs contain
siloxane groups on the external surface, whereas aluminol groups
are present in the inner lumen. The possibility of modifying both
surfaces via both chemical and supramolecular interactions opens
up a lot of ways to use these interesting nanomaterials in several
fields, especially in drug transport and delivery. The introduction of
specific groups to HNT surfaces is an important task since it enables
synergy between drugs with diﬀerent physicochemical and biologi-
cal properties as well as a diﬀerent path release. Furthermore, it is
possible to aﬀect a triggered release based on an external stimulus.
Finally, the presence of target moieties allows the cellular uptake of
the nanomaterial and in the same cases, it is demonstrated that the
carrier can overcome the cellular barrier, even penetrating into cell
nuclei. Several biological tests highlight that halloysite is a safe
material and therefore it is promising for specific applications for
the treatment of several diseases. In the light of the fact that
halloysite is used as a non-injectable drug formulation, interest in
its use as a drug carrier and delivery system depends on its
incorporation into oral tablets, sprays, creams and so on.
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